NCT04088292View on ClinicalTrials.gov

Low Dose Thrombolysis, Ultrasound Assisted Thrombolysis or Heparin for Intermediate High Risk Pulmonary Embolism

PHASE3Active, not recruitingINTERVENTIONAL
Enrollment

210

Participants

Timeline

Start Date

June 6, 2019

Primary Completion Date

June 5, 2024

Study Completion Date

November 30, 2024

Conditions
Pulmonary Embolism
Interventions
DRUG

Alteplase 20 Mg Powder for Solution for Injection Vial

Low dose alteplase delivered IV or bu Ultrasound Assisted Thrombolysis device

DEVICE

Ultrasound assisted Thrombolysis

Ultrasound assisted thrombolysis (USAT)

Trial Locations (4)

2900

Copenhagen University Hospital Gentofte, Gentofte Municipality

DK2400

Copenhagen University Hospital Bispebjerg Hospital, Bispebjerg

DK2100

Copenhagen University Hospital Rigshospitalet, Copenhagen

DK2730

Copenhagen University Hospital, Herlev Gentofte Hospital, Herlev

All Listed Sponsors
collaborator

Herlev and Gentofte Hospital

OTHER

collaborator

University Hospital Bispebjerg and Frederiksberg

OTHER

collaborator

Hillerod Hospital, Denmark

OTHER

collaborator

Copenhagen University Hospital, Hvidovre

OTHER

lead

Rigshospitalet, Denmark

OTHER